S-1/A: Jefferson Capital, Inc. Advances IPO with Detailed Underwriting and Governance Filings

Sentiment:

IPO Registration Amendment 23 June 2025 11:46 PM

📋All filings for Jefferson Capital, INC / De

Jefferson Capital, Inc. filed an exhibits-only amendment to its S-1 registration statement, outlining the terms of its proposed initial public offering of up to 11.5 million shares, alongside new corporate governance documents and a comprehensive stockholders agreement.

Capital raiseThe company proposes an initial public offering (IPO) of up to 11,500,000 shares of common stock.This includes 625,000 shares to be sold by the company and 9,375,000 shares by selling stockholders (Firm Shares).Underwriters have an option to purchase an additional 1,500,000 shares from selling stockholders (Optional Shares).The IPO is a primary mechanism for the company to raise capital and for existing shareholders to monetize their holdings.

Summary

Amendment No. 3 to Form S-1 Registration Statement (File No. 333-287488) was filed by Jefferson Capital, Inc. on June 23, 2025, as an exhibits-only filing, with the core S-1 content remaining unchanged.
The company proposes an initial public offering (IPO) of 10,000,000 common shares (Firm Shares), comprising 625,000 shares from the company and 9,375,000 shares from various selling stockholders.
Underwriters have been granted an option to purchase up to an additional 1,500,000 shares (Optional Shares) from the selling stockholders, potentially increasing the total offering to 11,500,000 shares.
Up to 5% of the Firm Shares (500,000 shares) are allocated for a Directed Share Program, targeting eligible directors, officers, employees, and individuals with business relationships with the company.
The common stock has a par value of $0.0001 per share, with 330,000,000 common shares and 50,000,000 preferred shares authorized.
The company intends to list its Offered Shares on the Nasdaq Global Select Market, subject to official notice of issuance.
New corporate governance documents, including an Amended and Restated Certificate of Incorporation and Bylaws, will become effective upon completion of the IPO, establishing a classified board, specific director removal provisions, and restrictions on stockholder action by written consent after a 'Trigger Date' (JCF Stockholders owning less than 40% of common stock).
A Stockholders Agreement outlines extensive rights for JCF Stockholders, including board representation based on ownership percentage, committee appointments, and consent rights over significant corporate actions (e.g., acquisitions/dispositions over $100 million, indebtedness over $150 million, changes in board size, reorganizations, and adverse amendments to governing documents).
The company has opted out of Section 203 of the DGCL but implemented its own business combination restrictions, with exemptions for JCF Stockholders and their transferees.
A corporate opportunity waiver is included, allowing JCF Stockholders and their affiliates to pursue business opportunities that might otherwise be corporate opportunities for Jefferson Capital, Inc., unless expressly offered to them in their capacity as a company director/officer/employee.

Sentiment

Score: 6

Explanation: The document outlines the procedural steps and agreements for an initial public offering, which is a positive development for the company's growth and liquidity. However, as an exhibits-only filing, it lacks new financial or operational performance data, preventing a higher sentiment score based on business fundamentals.

Positives

Proceeding with an IPO indicates a strategic move towards public market access and potential capital for future growth initiatives.
The structured registration rights for major stockholders (JCF Stockholders) provide a clear framework for future liquidity and orderly market sales.
The establishment of a formal corporate governance framework, including a classified board and defined committee structures, is a positive step for a company transitioning to public ownership.
The Directed Share Program allows for participation by key stakeholders, potentially fostering alignment and broader ownership engagement.

Negatives

The filing is exhibits-only, meaning no new financial or operational updates are provided, which limits a comprehensive assessment of current company performance.
The specific purchase price per share for the IPO is not disclosed in the provided text, which is a critical missing financial detail for investors.
The 'Trigger Date' for changes in corporate governance (JCF Stockholders collectively ceasing to own at least 40% of common stock) indicates a significant initial level of control by JCF Stockholders, which could be perceived as a governance concern by some investors.
The corporate opportunity waiver could allow JCF Stockholders and their affiliates to pursue business opportunities that might otherwise benefit the company, potentially creating conflicts of interest.

Risks

**Market Conditions:** The success of the IPO is subject to prevailing market conditions, and the underwriting agreement allows for termination under adverse market or economic circumstances.
**Underwriter Default:** There is a risk that one or more underwriters may fail or refuse to purchase their agreed-upon shares, which could lead to the termination or postponement of the offering.
**Selling Stockholder Default:** A similar risk exists if selling stockholders fail to deliver the shares they have agreed to sell, potentially impacting the offering's completion.
**Lock-up Restrictions:** While common, the 180-day lock-up period for insiders and major shareholders could lead to a significant increase in tradable shares after its expiration, potentially impacting the share price.
**Corporate Opportunity Waiver:** The Certificate of Incorporation includes a waiver of corporate opportunities for 'Identified Persons' (JCF Stockholders and their affiliates), which could allow them to pursue business opportunities that might otherwise benefit the company, potentially creating conflicts of interest and limiting the company's growth prospects.
**Controlled Company Status:** The company's intention to avail itself of 'controlled company' exemptions may reduce certain corporate governance requirements (e.g., majority independent board, independent compensation/nominating committees), potentially impacting independent oversight and minority shareholder protections.
**Concentrated Ownership/Control:** JCF Stockholders retain significant influence over board composition and require consent for major corporate actions (e.g., acquisitions > $100M, indebtedness > $150M, changes in board size, reorganizations, and amendments to governing documents) as long as they hold at least 10% of outstanding common stock, which could limit management's flexibility and minority shareholder influence.
**Litigation Risk:** The indemnification provisions in the underwriting agreement and bylaws highlight potential legal claims or proceedings related to the offering or company operations, which could result in significant costs.
**Dilution:** Future issuances of shares under employee benefit plans or in connection with acquisitions/mergers, as permitted by the lock-up agreement, could lead to dilution for existing shareholders.

Future Outlook

The proposed sale to the public is expected to commence as soon as practicable after the Registration Statement is declared effective. The company will apply the net proceeds from its sale of offered shares in the manner described in the prospectus.

Management Comments

The company has complied, to the Commission's satisfaction, with all requests for additional or supplemental information.
The company and its subsidiaries have been and are in compliance with all applicable laws, rules and regulations, except where failure to be so in compliance would not reasonably be expected, individually or in the aggregate, to result in a Material Adverse Change.
The company will use its best efforts to list, subject to notice of issuance, the Offered Shares on the Nasdaq.

Industry Context

The filing represents a standard procedural step for a company pursuing an initial public offering, indicating Jefferson Capital, Inc.'s intent to access public capital markets. This move aligns with a broader trend of companies seeking liquidity and growth capital through public offerings. The involvement of multiple underwriters suggests a broad market interest in the potential offering.

Corporate Governance

Change Type	Description	Effective Date	Impact Assessment
Board Structure	The Board of Directors will be classified into three classes (Class I, Class II, Class III) with staggered three-year terms, with initial terms expiring at the 2026 and 2027 annual meetings.	Upon completion of the IPO	Establishes a staggered board, which can enhance stability but may also make board takeovers more difficult.
Director Removal	Prior to the 'Trigger Date' (JCF Stockholders owning less than 40% of common stock), directors can be removed with or without cause by a majority vote. After the Trigger Date, removal requires a 66 2/3% vote and only for cause. Removal of any JCF Director requires JCF Stockholders' consent.	Upon completion of the IPO	Strengthens board stability and protects JCF Stockholders' influence, particularly after the 'Trigger Date', potentially limiting shareholder ability to effect change.
Stockholder Action by Written Consent	Stockholder action by written consent is permitted prior to the 'Trigger Date'. After the 'Trigger Date', any stockholder action must be effected at an annual or special meeting, not by written consent.	Upon completion of the IPO	Restricts shareholder ability to act quickly without a meeting once JCF Stockholders' ownership falls below 40%, potentially reducing shareholder activism.
Special Meetings of Stockholders	Special meetings can only be called by the Board, Chairman, CEO, President, or a Board-selected officer. Prior to the 'Trigger Date', special meetings can also be called at the request of the JCF Stockholders.	Upon completion of the IPO	Limits the ability of non-JCF stockholders to call special meetings, centralizing control with the Board and JCF Stockholders initially.
JCF Stockholders Board Representation	JCF Stockholders have the right to designate a certain number of directors based on their aggregate ownership of outstanding common stock, ranging from 4 directors (>=50%) down to 1 director (>=10%). They also have the exclusive right to fill vacancies for JCF Directors.	Upon completion of the IPO	Ensures significant representation and influence for JCF Stockholders on the Board, reflecting their substantial ownership stake.
Board Committee Representation	JCF Stockholders have the right to have one JCF Director appointed to serve on each Board committee, subject to applicable laws and independence requirements, as long as they can designate at least one director to the Board.	Upon completion of the IPO	Extends JCF Stockholders' influence to Board committees, allowing them to participate in key decision-making processes.
Controlled Company Status	The company intends to avail itself of all available 'controlled company' exceptions to corporate governance listing standards of any securities exchange, unless waived by JCF Stockholders.	Upon completion of the IPO	Allows the company to be exempt from certain corporate governance requirements (e.g., majority independent board, independent compensation/nominating committees), which may reduce independent oversight.
JCF Stockholders Consent Rights	As long as JCF Stockholders and their affiliates hold at least 10% of outstanding common stock, their prior written consent is required for significant corporate actions, including acquisitions/dispositions over $100M, transactions leading to a change of control, incurrence/refinancing of indebtedness over $150M, changes in Board size, reorganizations, and adverse amendments to governing documents.	Upon completion of the IPO	Grants JCF Stockholders substantial veto power over major strategic and financial decisions, indicating their continued significant control and influence post-IPO.
Corporate Opportunity Waiver	The Certificate of Incorporation includes a waiver of corporate opportunities for 'Identified Persons' (JCF Stockholders and their affiliates, and their directors/officers/employees serving on the Company Board), allowing them to pursue business opportunities that might otherwise be corporate opportunities for the company, unless expressly offered to them solely in their capacity as a Company director/officer/employee.	Upon completion of the IPO	Potentially creates conflicts of interest and limits the company's ability to pursue certain business opportunities, favoring JCF Stockholders' other investments.
DGCL Section 203 Opt-Out and Custom Business Combination Provisions	The company elects not to be governed by Section 203 of the DGCL but implements its own business combination restrictions, including a three-year moratorium with 'interested stockholders' (15% owner) unless specific conditions are met. JCF Stockholders and their transferees are exempt from these restrictions.	Upon completion of the IPO	Provides a tailored anti-takeover defense while exempting the controlling JCF Stockholders, reinforcing their long-term influence.

Related Party Transactions

The Stockholders Agreement details extensive rights and influence granted to JCF Stockholders, including board representation, committee appointments, consent rights over significant corporate actions, and access to company information.
The Certificate of Incorporation includes a corporate opportunity waiver that benefits JCF Stockholders and their affiliates, allowing them to pursue business opportunities that might otherwise be available to Jefferson Capital, Inc.
The exemption of JCF Stockholders from the company's custom business combination restrictions (despite opting out of DGCL Section 203) is a related party benefit.

Stakeholder Impact

**Shareholders (New):** Will acquire common stock in a company with a classified board, significant control by JCF Stockholders, and specific corporate opportunity waivers. They will have registration rights for future sales.
**Shareholders (Existing/Selling Stockholders):** Will monetize a portion of their holdings through the IPO and retain significant governance rights and influence through the Stockholders Agreement.
**Employees:** Eligible for participation in the Directed Share Program and benefit from existing and new incentive award plans (e.g., 2025 Incentive Award Plan).
**Management:** Key executives like David Burton and Christo Realov are involved in the IPO process and are subject to lock-up agreements. Their roles and compensation are governed by existing agreements.
**Creditors:** The company's existing debt instruments (Senior Notes due 2026, 2029, 2030) and credit agreements are referenced, indicating ongoing financial obligations. The IPO proceeds may impact the company's financial leverage.

Next Steps

Declaration of effectiveness of the Registration Statement by the SEC.
Commencement of the public sale of Offered Shares.
Listing of Offered Shares on the Nasdaq Global Select Market.
Potential exercise of the over-allotment option by underwriters within 30 days of the Underwriting Agreement.
Company to make generally available an earnings statement covering at least twelve months after the agreement date to satisfy Securities Act provisions.
Company to comply with ongoing SEC and Nasdaq filing requirements.

Key Dates

Date	Description
2018-03-20	Amended and Restated Senior Management Agreement with David Burton.
2021-05-21	Original Credit Agreement date with Citizens Bank, N.A.
2021-08-04	Indenture date for 6.000% Senior Notes due 2026.
2021-12-28	Amendment No. 1 to Credit Agreement.
2022-02-28	Amendment No. 2 to Credit Agreement.
2023-04-26	Amendment No. 3 to Credit Agreement.
2023-09-29	Amendment No. 4 to Credit Agreement.
2024-02-02	Indenture date for 9.500% Senior Notes due 2029.
2024-06-03	Amendment No. 5 to Credit Agreement.
2024-10-02	Asset Purchase Agreement by Jefferson Capital Systems, LLC as Purchaser, with Conns, Inc. and others as Sellers.
2024-11-12	Original Certificate of Incorporation filing date.
2024-11-13	Amendment No. 6 to Credit Agreement.
2025-05-02	Indenture date for 8.250% Senior Notes due 2030.
2025-06-10	Deemed preceding year's annual meeting date for the first annual meeting of stockholders following the IPO (for bylaw purposes).
2025-06-23	S-1/A filing date; Underwriting Agreement signed date; Signatures by David Burton and Christo Realov.
2025-08-31	Latest date for Underwriting Agreement execution before lock-up termination (with possible 3-month extension by company).
TBD	Approximate date of commencement of proposed sale to public: As soon as practicable after Registration Statement is declared effective.
TBD	First Closing Date for Firm Shares (placeholder in agreement).
TBD	Latest First Closing Date (placeholder in agreement).
TBD	Option Closing Date for Optional Shares (if option exercised).
TBD	Effective date of Amended and Restated Certificate of Incorporation and Bylaws (upon completion of the IPO).
TBD	Effective date of Stockholders Agreement (upon IPO closing).
TBD	Expiration of Lock-up Period (180 days after Prospectus date).
TBD	Expiration of initial term for Class I Directors (following 2026 annual meeting).
TBD	Expiration of initial term for Class II and Class III Directors (following 2027 annual meeting).

Keywords

Jefferson Capital Inc., IPO, S-1/A, Underwriting Agreement, Stockholders Agreement, Corporate Governance, Registration Rights, Common Stock Offering, SEC Filing, J.C. Flowers & Co., Nasdaq Listing, Controlled Company, Capital Raise

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.